Related Experiment Video

Updated: Oct 2, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

[Acute hepatitis C in the presence of chronic HBV infection]

T V Shkurko, S G Cheshik, D M Braginskiĭ

    Voprosy Virusologii
    |February 21, 2002
    PubMed

    Insights

    This study examined acute hepatitis C virus (HCV) superinfection in patients with chronic hepatitis B virus (HBV) infection. Results showed HBV DNA replication was predominant, with HCV RNA present in fewer patients, impacting clinical presentation.

    Area of Science:

    • Hepatology
    • Virology
    • Infectious Diseases

    Background:

    • Chronic hepatitis B virus (HBV) infection is a global health concern.
    • Hepatitis C virus (HCV) infection can occur in individuals with pre-existing HBV.
    • Understanding superinfection dynamics is crucial for patient management.

    Purpose of the Study:

    • To investigate the clinical course and virological characteristics of acute HCV superinfection in patients with chronic HBV infection.
    • To compare the replication patterns of HBV and HCV in a superinfected cohort.
    • To analyze the impact of HBV on the clinical presentation of acute HCV.

    Main Methods:

    • Serological detection of HBsAg and anti-HCV antibodies (C-100, core, NS3, NS5).
    • Quantification of HBV DNA and HCV RNA in patient sera.
    • Clinical assessment of symptoms, biochemical markers, and disease duration.

    Main Results:

    • HBV DNA replication was predominant (68%) compared to HCV RNA (24%) in the studied patients.
    • Acute HCV superinfection generally mirrored HCV monoinfection clinically.
    • More pronounced biochemical shifts and shorter intoxication periods were observed in the superinfected group.

    Conclusions:

    • HBV replication is dominant during acute HCV superinfection in chronic HBV patients.
    • Clinical outcomes of HCV superinfection are similar to monoinfection but with distinct biochemical and symptomatic profiles.
    • The interplay between HBV and HCV in superinfection warrants further investigation.

    More Related Videos

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Cytomegalovirus Disease01:27

    Cytomegalovirus Disease

    Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...